Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr Reddy's gets prelim FDA nod for asthma drug

Date: 10-06-2010

Dr Reddy's Laboratories (REDY.BO) has got tentative approval from U.S. regulators to launch the generic version of AstraZeneca's (AZN.L) Accolate, used to treat asthma.

The company is currently working on manufacturing plans for zafirlukast, the generic name of Accolate, and will decide the time of its launch after getting the final approval from the U.S. Food & Drug Administration. The company expects the launch of more than a dozen new drugs in the United States to boost growth in this financial year. crackcrack